The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Guillaume Ploussard; Alexander Haese; Van Poppel Hendrik; Michael Marberger; Arnulf Stenzl; Peter F A Mulders; Hartwig Huland; Laurence Bastien; Clèment-Claude Abbou; Mesut Remzi; Martina Tinzl; Susan Feyerabend; Alexander B Stillebroer; Van Gils; P M Q Martijn; Jack A Schalken; Alexandre de La Taille

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Standard

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies? / Ploussard, Guillaume; Haese, Alexander; Hendrik, Van Poppel; Marberger, Michael; Stenzl, Arnulf; Mulders, Peter F A; Huland, Hartwig; Bastien, Laurence; Abbou, Clèment-Claude; Remzi, Mesut; Tinzl, Martina; Feyerabend, Susan; Stillebroer, Alexander B; Gils, Van; Martijn, P M Q; Schalken, Jack A; de La Taille, Alexandre.

In: BJU INT, Vol. 106, No. 8, 8, 2010, p. 1143-1147.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Ploussard, G, Haese, A, Hendrik, VP, Marberger, M, Stenzl, A, Mulders, PFA, Huland, H, Bastien, L, Abbou, C-C, Remzi, M, Tinzl, M, Feyerabend, S, Stillebroer, AB, Gils, V, Martijn, PMQ, Schalken, JA & de La Taille, A 2010, 'The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?', BJU INT, vol. 106, no. 8, 8, pp. 1143-1147. <http://www.ncbi.nlm.nih.gov/pubmed/20230386?dopt=Citation>

APA

Ploussard, G., Haese, A., Hendrik, V. P., Marberger, M., Stenzl, A., Mulders, P. F. A., Huland, H., Bastien, L., Abbou, C-C., Remzi, M., Tinzl, M., Feyerabend, S., Stillebroer, A. B., Gils, V., Martijn, P. M. Q., Schalken, J. A., & de La Taille, A. (2010). The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies? BJU INT, 106(8), 1143-1147. [8]. http://www.ncbi.nlm.nih.gov/pubmed/20230386?dopt=Citation

Vancouver

Ploussard G, Haese A, Hendrik VP, Marberger M, Stenzl A, Mulders PFA et al. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies? BJU INT. 2010;106(8):1143-1147. 8.

Bibtex

@article{cc51d67fb10d41ec97c36e0728a28a06,

title = "The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?",

abstract = "to determine the performance characteristics of the prostate cancer gene 3 (PCA3) score on the outcome of biopsy relative to different ranges of free-to-total prostate-specific antigen (PSA) ratio (f/tPSA) in men with a previous negative biopsy and a PSA level of 2.5-10 ng/mL, as urine tests like PCA3 are currently under investigation in order to improve prostate cancer diagnosis and to decrease the rate of unnecessary rebiopsies.",

author = "Guillaume Ploussard and Alexander Haese and Hendrik, {Van Poppel} and Michael Marberger and Arnulf Stenzl and Mulders, {Peter F A} and Hartwig Huland and Laurence Bastien and Cl{\`e}ment-Claude Abbou and Mesut Remzi and Martina Tinzl and Susan Feyerabend and Stillebroer, {Alexander B} and Van Gils and Martijn, {P M Q} and Schalken, {Jack A} and {de La Taille}, Alexandre",

year = "2010",

language = "Deutsch",

volume = "106",

pages = "1143--1147",

journal = "BJU INT",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "8",

}

RIS

TY - JOUR

T1 - The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

AU - Ploussard, Guillaume

AU - Haese, Alexander

AU - Hendrik, Van Poppel

AU - Marberger, Michael

AU - Stenzl, Arnulf

AU - Mulders, Peter F A

AU - Huland, Hartwig

AU - Bastien, Laurence

AU - Abbou, Clèment-Claude

AU - Remzi, Mesut

AU - Tinzl, Martina

AU - Feyerabend, Susan

AU - Stillebroer, Alexander B

AU - Gils, Van

AU - Martijn, P M Q

AU - Schalken, Jack A

AU - de La Taille, Alexandre

PY - 2010

Y1 - 2010

N2 - to determine the performance characteristics of the prostate cancer gene 3 (PCA3) score on the outcome of biopsy relative to different ranges of free-to-total prostate-specific antigen (PSA) ratio (f/tPSA) in men with a previous negative biopsy and a PSA level of 2.5-10 ng/mL, as urine tests like PCA3 are currently under investigation in order to improve prostate cancer diagnosis and to decrease the rate of unnecessary rebiopsies.

AB - to determine the performance characteristics of the prostate cancer gene 3 (PCA3) score on the outcome of biopsy relative to different ranges of free-to-total prostate-specific antigen (PSA) ratio (f/tPSA) in men with a previous negative biopsy and a PSA level of 2.5-10 ng/mL, as urine tests like PCA3 are currently under investigation in order to improve prostate cancer diagnosis and to decrease the rate of unnecessary rebiopsies.

M3 - SCORING: Zeitschriftenaufsatz

VL - 106

SP - 1143

EP - 1147

JO - BJU INT

JF - BJU INT

SN - 1464-4096

IS - 8

M1 - 8

ER -